Viatris Inc.
$14.78
▲
0.31%
2026-04-22 10:12:13
www.viatris.com
NMS: VTRS
Explore Viatris Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$17.2 B
Current Price
$14.78
52W High / Low
$16.47 / $7.39
Stock P/E
—
Book Value
$12.78
Dividend Yield
3.23%
ROCE
0.84%
ROE
-21.08%
Face Value
—
EPS
$-3
Exp Qtr EPS
—
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
30,000
Beta
0.82
Debt / Equity
99.91
Current Ratio
1.38
Quick Ratio
0.82
Forward P/E
5.05
Price / Sales
1.1
Enterprise Value
$28.69 B
EV / EBITDA
7.25
EV / Revenue
2.01
Rating
Buy
Target Price
$15.72
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
- Meaningful dividend yield is available.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Assertio Holdings, Inc. | $18.14 | — | $116.08 M | — | -12.35% | -28.25% | $20.45 / $8.55 | $14.63 |
| 2. | TherapeuticsMD, Inc. | $2.19 | 83.93 | $25.35 M | — | -12.82% | -2.41% | $2.95 / $0.95 | $2.32 |
| 3. | SIGA Technologies, Inc. | $4.57 | 14.06 | $327.41 M | 0% | 11.76% | 11.23% | $9.62 / $4.29 | $2.78 |
| 4. | Kiniksa Pharmaceuticals International, plc | $42.46 | 55.07 | $3.25 B | — | 12.37% | 11.73% | $50.03 / $19.62 | $7.44 |
| 5. | Aurora Cannabis Inc. | $3.72 | — | $285.82 M | — | 1.34% | -15.51% | $9.33 / $4.29 | $6.8 |
| 6. | Incannex Healthcare Inc. | $3.84 | — | $51 M | — | — | -1.3% | $49.8 / $2.4 | $6.13 |
| 7. | BioAge Labs, Inc. | $18.8 | — | $820.58 M | — | -33.77% | -27.09% | $24 / $3.63 | $7.28 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 3.7 B | 3.76 B | 3.58 B | 3.25 B | 3.53 B |
| Operating Profit | -157.5 M | 234.5 M | 185.4 M | -8.9 M | -38.2 M |
| Net Profit | -340.1 M | -128.2 M | -4.6 M | -3.04 B | -516.5 M |
| EPS in Rs | -0.29 | -0.11 | -0 | -2.61 | -0.44 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 14.3 B | 14.74 B | 15.43 B | 16.26 B |
| Operating Profit | 253.5 M | 710.3 M | 1.56 B | 1.66 B |
| Net Profit | -3.51 B | -634.2 M | 54.7 M | 2.08 B |
| EPS in Rs | -3.02 | -0.54 | 0.05 | 1.79 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 37.19 B | 41.5 B | 47.69 B | 50.02 B |
| Total Liabilities | 22.48 B | 22.87 B | 27.22 B | 28.95 B |
| Equity | 14.71 B | 18.64 B | 20.47 B | 21.07 B |
| Current Assets | 9.79 B | 9.52 B | 12.98 B | 10.64 B |
| Current Liabilities | 7.09 B | 5.78 B | 7.78 B | 6.75 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 2.32 B | 2.3 B | 2.9 B | 3 B |
| Investing CF | -427.7 M | 1.8 B | -864.5 M | 1.47 B |
| Financing CF | -1.29 B | -4.33 B | -2.3 B | -3.88 B |
| Free CF | 1.85 B | 1.94 B | 2.33 B | 2.51 B |
| Capex | -465.1 M | -359.1 M | -574.9 M | -489.4 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | -2.98% | -4.46% | -5.14% | — |
| Earnings Growth % | -454.23% | -1259.41% | -97.37% | — |
| Profit Margin % | -24.58% | -4.3% | 0.35% | 12.78% |
| Operating Margin % | 1.77% | 4.82% | 10.13% | 10.18% |
| Gross Margin % | 35.06% | 38.15% | 41.74% | 39.95% |
| EBITDA Margin % | -2.77% | 19.13% | 22.79% | 39.56% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-03-09 | $0.12 |
| 2025-11-24 | $0.12 |
| 2025-08-22 | $0.12 |
| 2025-05-23 | $0.12 |
| 2025-03-10 | $0.12 |
Stock Splits
No stock split history available.